nur77, an immediate-early gene that encodes an orphan nuclear receptor, is rapidly and transiently induced by nerve growth factor (NGF) stimulation or membrane depolarization in the rat pheochromocytoma-derived cell line PC12. The Nur77 protein can act as a potent transcription activator and may function to regulate the expression of downstream genes in response to extracellular stimuli. We show here that activation of nur77 by NGF treatment and membrane depolarization is signalled through distinct pathways. These distinct signals appear to converge on the same transcription factors acting on the same promoter elements. We show that nur77 activation by both processes requires two cis-acting APi-like elements, NAPI and NAP2, which contain the core sequence TGCGTCA centered at 67 and 38 nucleotides upstream of the transcription start site. The NAP elements can confer inducibility by NGF and membrane depolarization on an otherwise unresponsive heterologous promoter. We identified JunD as a key mediator of nur77 activation by reason of the following observations. (i) JunD, but not CREB or other members of the Fos/Jun family, is a component of NAP binding activity in PC12 cell nuclear extracts. (ii) JunD, but not other Fos/Jun family members, specifically transactivates the nur77 promoter through the NAP elements (iii) A dominant-negative mutant of JunD effectively abolishes the activation of nur77 by either NGF treatment or membrane depolarization. These data draw a contrast between the regulation of nur77 with that of c-fos, in which the sequence requirements for activation by NGF treatment and membrane depolarization appear separable, and CREB appears to play a role in activation by both NGF and membrane depolarization.
nur77, an immediate-early gene that encodes an orphan nuclear receptor, is rapidly and transiently induced by nerve growth factor (NGF) stimulation or membrane depolarization in the rat pheochromocytoma-derived cell line PC12. The Nur77 protein can act as a potent transcription activator and may function to regulate the expression of downstream genes in response to extracellular stimuli. We show here that activation of nur77 by NGF treatment and membrane depolarization is signalled through distinct pathways. These distinct signals appear to converge on the same transcription factors acting on the same promoter elements. We show that nur77 activation by both processes requires two cis-acting APi-like elements, NAPI and NAP2, which contain the core sequence TGCGTCA centered at 67 and 38 nucleotides upstream of the transcription start site. The NAP elements can confer inducibility by NGF and membrane depolarization on an otherwise unresponsive heterologous promoter. We identified JunD as a key mediator of nur77 activation by reason of the following observations. (i) JunD, but not CREB or other members of the Fos/Jun family, is a component of NAP binding activity in PC12 cell nuclear extracts. (ii) JunD, but not other Fos/Jun family members, specifically transactivates the nur77 promoter through the NAP elements (iii) A dominant-negative mutant of JunD effectively abolishes the activation of nur77 by either NGF treatment or membrane depolarization. These data draw a contrast between the regulation of nur77 with that of c-fos, in which the sequence requirements for activation by NGF treatment and membrane depolarization appear separable, and CREB appears to play a role in activation by both NGF and membrane depolarization.
The primary genetic response in mammalian cells exposed to a variety of extracellular signalling agents is the rapid and transient induction of a set of genes, called immediate-early genes (28, 36) . The induction of these genes does not require de novo protein synthesis and is likely to be mediated by the posttranslational modification of existing transcription factors. Many immediate-early genes are known to encode transcription factors thought to regulate the expression of downstream genes, which may in turn act as effectors of the cellular responses to the extracellular stimuli.
A particularly interesting cell culture system for studying transcriptional activation of immediate-early genes is the rat pheochromocytoma-derived cell line PC12, since it can undergo disparate cellular processes depending on the stimulating agents (15, 21, 22) . Nerve growth factor (NGF) stimulates PC12 cells to differentiate into sympathetic neuron-like cells, whereas epidermal growth factor is mitogenic without inducing differentiation. In addition, PC12 cells have excitable membranes that could be depolarized by specific neurotransmitters or elevated levels of extracellular KCl (13, 20, 22) . Thus, PC12 cells provide a model for studying gene regulation in response to agents that induce either differentiation or proliferation or to stimuli that mimic neurotransmission.
Among immediate-early genes, the proto-oncogene c-fos has been the most extensively studied with regard to its transcriptional regulation (2, 16, 47, 54, 60) . The activation of c-fos in PC12 cells by NGF, epidermal growth factor, or tetradecanoyl phorbol acetate (TPA) is mediated primarily through the serum response element (53, 63) . The c-fos serum response element contains a CArG box (41) , which binds to a 67-kDa serum response factor (59) , and an adjacent binding site for a protein of the Ets family, most likely Elk-1 or SAP-1 (7, 29, 38) . In contrast, transcriptional activation of c-fos by membrane depolarization, Ca2+ influx, and elevation of cyclic AMP (cAMP) is mediated through a cAMP response element (CRE)-like sequence that binds CREB in vitro (14, 53, 55) . The transcription efficacy of CREB is known to be modulated by phosphorylation on serine 133, either by the cAMP-dependent protein kinase A (PKA) (19, 71) or by the Ca2+/ calmodulin-dependent protein kinase II (CaMII kinase) (8, 56) . These results suggest that membrane depolarization might activate c-fos by activating CREB via signalling through cAMP-or Ca2+-dependent kinases. In addition, full induction of c-fos by NGF also requires intact CREs and involves the activation of CREB through a Ras-dependent protein kinase (17) .
To expand our knowledge of the mechanisms regulating immediate-early gene activation, we have studied the transcriptional regulation of the orphan nuclear receptor gene nur77 (72) . nur77 (also known as NJ0 and NGFI-B) (26, 40, 51) is rapidly and transiently induced by serum growth factors in fibroblasts (26, 66) and by NGF stimulation and membrane depolarization in PC12 cells with kinetics similar to those of c-fos (3, 40) . The nur77-encoded protein is a member of the steroid hormone receptor superfamily (26, 40) and has been shown to act as a potent transcriptional activator through interactions with DNA at sequence-specific sites (9, 10, 67, 68 (37, 70) .
In a previous study, we have shown that the promoter region spanning nucleotides (nt) 86 to 22 upstream of the transcription start site contains the cis-acting sequences that are both necessary and sufficient for induction by both NGF and KCl in PC12 cells (72) . This region contains two AP1-like elements (NAP-1 and NAP-2) and a GC-rich sequence that appear to be essential (72) . In contrast, sequences further upstream that contain a CArG-like element and an Elk binding site are required for induction by serum growth factors in mouse fibroblasts (66) .
In the present study, we have extensively analyzed the nur77 promoter to define more precisely the elements responsible for nur77 induction in PC12 cells. Although the signalling pathways mediating NGF 
MATERIALS AND METHODS
Cell culture. PC12 cells were grown as previously described (72) . Cells were stimulated with NGF (50 ng/ml), TPA (Sigma; 100 ng/ml), forskolin (Sigma; 20 jiM), or KCl (60 mM) for various durations as indicated below. The protein kinase inhibitors H-89 (4) and were dissolved in dimethyl sulfoxide according to the manufacturer's instructions (Seikagaku America Inc.) and added to culture medium to 20 and 10 jiM, respectively, 30 min before stimulation.
In vitro mutagenesis and plasmid construction. The construction of mutants M5, M6, and M7 was previously described (72) . Specific mutations of the nur77 promoter were created by site-directed in vitro mutagenesis (35) . Single-stranded M13 DNA containing the nur77 promoter spanning nt -126 to +122 was used as a template for mutagenesis as previously described (72) , using the oligonucleotides listed in Table 1 . 2NAP2 TKCAT (two copies of the NAP2 sequence) and 3SP1 TKCAT (three copies of the SP1 sequence) plasmids were constructed by inserting synthetic double-stranded oligonucleotides into the XbaI site of TKCAT plasmid. For 2NAP2 TKCAT, the oligonucleotide 5'-CTAGACTCTCCATGCGT CACGGAGCGCTCTCCATGCGTCACGGAGCGT was used with the corresponding complementary strand. For 3SP1 TKCAT, the oligonucleotide 5'-CTAGACCCGCCCTCTCCT was used with the corresponding complementary strand and three copies were inserted. nur77 promoter-luciferase fusion plasmids were made by transferring the nur77 promoter fragment containing nt -86 to +122 or the same region containing mutations in the NAP elements into NMel-and BgllI-digested pGL2Basic plasmid (Promega), which contains the luciferase reporter gene.
Protein expression plasmids for c-Fos, c-Jun, JunB, and JunD were made by placing the full-length mouse cDNA sequences under the control of the simian virus 40 (SV40) early promoter in plasmid pSG5 (Stratagene). A dominantnegative mutant of JunD (JunD mut) was created by an internal deletion of amino acids 271 to 283 of JunD. This mutated JunD sequence was inserted downstream of the cytomegalovirus promoter of pCMV5 (provided by Robert Costa, University of Illinois, Chicago).
The plasmids pSV2neo and pPGKf-gal, containing the neomycin resistance gene driven by the SV40 promoter or the P-galactosidase gene driven by the phosphoglycerate kinase promoter, respectively, were used as reference plasmids to determine transfection efficiency. Plasmid DNA for transfection was prepared by the alkaline lysis procedure followed by CsCl density gradient centrifugation as described previously (72) .
Transient transfection, S1 nuclease protection, and enzymatic assays. Transient transfection was performed by electroporation as described elsewhere (72) . Total RNA isolation and S1 nuclease protection were performed as previously described (72) . For enzymatic assays, transfected cells were washed with phosphate-buffered saline (PBS) and harvested in TEN buffer (40 mM Tris [pH 7.5], 1 mM EDTA, and 150 mM NaCl). Cell suspensions were split into two portions for preparing cell lysates for luciferase and 3-galactosidase assays. The luciferase assay was performed with the luciferase assay substrate (Promega), using the single-photon mode of a scintillation counter (Beckman). P-Galactosidase activities were measured as described elsewhere (52) .
RNA blot hybridization. Samples (10 ,ug) of total cellular RNA were subjected to electrophoresis on a 1.2% formaldehyde-agarose gel and then transferred to nitrocellulose filters. The filters were hybridized with 32P-labeled nur77 cDNA probe (26) or ct-tubulin cDNA probe (6) Immunoprecipitation of Fos-JunD heterodimers. Equal amounts of 35S-labeled, in vitro-translated Fos, JunD, or JunD mut proteins were mixed and allowed to form complexes at room temperature for 30 min. The protein mixtures were incubated with either anti-Fos antibodies (Oncogene Science) or anti-JunD antibodies for 1 h on ice and then incubated with protein A-Sepharose CL-4B (Pharmacia) for 1 h with constant shaking at 4°C. The immunoprecipitates were collected by centrifugation and washed with a buffer (10 mM Tris [pH 7.5], 150 mM NaCl, 2 mM EDTA, and 0.2% Nonidet P-40) three times and with 10 mM Tris (pH 7.5) once. The immunoprecipitated proteins were resolved by SDS-10% polyacrylamide gel electrophoresis (PAGE) followed by fluorography.
RESULTS
Distinct signalling pathways mediate induction of nur77 by NGF and KCI. In PC12 cells, nur77 is rapidly induced by stimulation with NGF and by membrane depolarization (3, 40) . In addition, nur77 can be induced by other agents such as TPA or forskolin (28, 36) , suggesting that nur77 induction may be mediated through the activation of protein kinases. To gain insight into the signal transduction pathways for nur77 activation, we have examined the possible roles of different protein kinases.
That TPA induces nur77 suggests that protein kinase C (PKC) is able to mediate nur77 activation. To determine whether PKC activity is obligatory for nur77 induction, we treated PC12 cells with TPA for 24 h to down-regulate PKC activity (48) . The induction of nur77 in response to NGF or KCl in TPA-treated cells was compared with that in untreated (Fig. 1A) . nur77 induction by TPA was observed after 1 h in naive cells but not in TPA-pretreated cells, demonstrating that PKC activity was effectively down-regulated. Treatment with NGF and KCl, however, resulted in similar levels of nur77 induction in TPA-pretreated cells and untreated cells (Fig.  1A) , indicating that induction of nur77 by NGF and KCl can occur through pathways that do not involve phorbol estersensitive PKC.
nur77 is activated by treatment with forskolin, suggesting that the cAMP-dependent PKA may be involved in its activation (Fig. 1B) . To test whether PKA is required for activation of nur77 by NGF or KCl, we treated cells with the known PKA inhibitor H-89 (4) for 30 min prior to NGF or KCl stimulation (Fig. 1B) . The activation of nur77 by NGF was partially inhibited in the presence of H-89. In contrast, nur77 activation by either KCl or forskolin was completely blocked by the inhibitor. These results indicate that PKA may mediate one (CHX) , and total cellular RNA was analyzed by an S1 nuclease protection assay. Protected products corresponding to transcripts from the transfected minigene, the endogenous nur77, and the neo gene are indicated. component of nur77 activation by NGF but plays a major role in the activation of nur77 by KCl.
Since the main effect of KCl treatment in PC12 cells is the increase of intracellular Ca2+ levels through the influx of extracellular Ca2+ (13, 20, 22) , we tested whether CaMII kinase can mediate nur77 activation by treating cells with the CaMII kinase-specific inhibitor KN-62 (58) before NGF or KCl stimulation (Fig. 1C) . The activation of nur77 by KCl was completely inhibited by KN-62, whereas activation by NGF was not significantly affected. Therefore, CaMII kinase may be involved in the activation of nur77 by KCl but not in activation by NGF. Although pharmacological approaches in the analysis of signalling pathways have limitations with regard to the specificity of the compounds used, our results show that induction by NGF and KCl is differentially affected by the same compounds. Taken together, these results show that nur77 activation by NGF or KCl is mediated through distinct and separable pathways and suggest that PKA and CaMII kinase may play major roles in the activation by membrane depolarization.
Accurate transcription kinetics of transfected nur77 minigenes. The kinetics of nur77 expression in NGF-or KClstimulated PC12 cells are rapid and transient (3) , suggesting that transcriptional repression, or the loss of activation, occurs soon after the onset of transcriptional activation upon stimulation. We previously reported that a nur77 minigene containing 1.1 kb of sequences upstream of the transcription start site is expressed with kinetics identical to those of the endogenous nur77 gene (72) . Here, we show that the sequence information that specifies these expression kinetics is encoded within the first 126 bp upstream of the transcription start site, contained in the 126/77TR minigene (Fig. 2) . The 126/77TR minigene was transfected into PC12 cells, and the time course of expression of the transfected gene was analyzed (Fig. 2B) . As described previously, the endogenous levels of nur77 mRNA induced by NGF reached a peak by 1 h and declined to the unstimulated level by 3 h, whereas the expression induced by KCl exhibited slightly more prolonged kinetics (72) . The transfected nur77 minigene is expressed with kinetics virtually identical to those of the endogenous nur77 and was superinduced by the protein synthesis inhibitor cycloheximide.
NAPi and NAP2 are the major cis-acting elements for NGF and KCI stimulation. We previously reported that a DNA fragment containing nt -90 to -22 of the nur77 promoter can confer inducibility by NGF or KCl on a heterologous promoter (72) . Within this DNA fragment, there are two APi-like sequences (NAP1 and NAP2), two overlapping SPI binding sites, and a Zif268 binding site (5) (Fig. 3A) . To determine more precisely the promoter sequences required for activation of nur77, we created a series of base substitution mutations in the context of the 126/77TR minigene (Fig. 3A) . The promoter activities of these mutant minigenes were analyzed by S1 .GCGCTTAAGATGT( TATA-like (-) or stimulated with NGF (N) or KCI (K) for 1 h, and expression of the fusion genes was analyzed by S1 nuclease protection assay of the CAT message as described elsewhere (72) . The protected products corresponding to the correctly initiated CAT transcript and the neo reference transcript are indicated, as is a nonspecific product (*).
we created a mutation that disrupted only the Zif268 binding site without affecting the SP1 binding sites (M11) and a mutation that disrupted both the SP1 and the Zif268 binding sites (M6). The M11 construct showed strong induction by both NGF and KCl, whereas M6 exhibited no induction (Fig.  3B) , indicating that the Zif268 site is not essential for activation of nur77 by NGF and KC1. Mutations of the 3'-flanking region of the SP1 sites (M12 and M13) showed no effect. Taken together, these results indicate that the NAP1, NAP2, and SP1 elements are essential for induction of nur77 by NGF and KCL. Thus, although we have shown that induction by NGF and KCl is mediated through distinct signalling pathways (Fig. 1) , the sequence requirements for induction by these agents appear to be indistinguishable.
To further evaluate the roles of the NAP elements and SP1 sites in nur77 activation, we examined their ability to confer inducibility on a heterologous promoter. We tested two specific constructs, one containing two copies of a region bearing the NAP2 element (nt -48 to -28) of the nur77 promoter (2NAP2 TKCAT; Fig. 4A ) and the other containing three copies of the SP1 site (3SP1 TKCAT; Fig. 4A ) cloned upstream of the thymidine kinase promoter driving expression of the chloramphenicol acetyltransferase (CAT) gene. Following transient transfection, the CAT transcript was detected by S1 nuclease protection assay (Fig. 4B) . The parental vector, TKCAT, which contains the thymidine kinase basal promoter, showed no induction whatever by either NGF or KC1. In contrast, a construct that contains nt -90 to -22 of the nur77 promoter exhibited efficient induction by both NGF and KC1, as previously reported (72) . The 2NAP2 TKCAT construct showed strong induction by both NGF and KCl (Fig. 4B) , indicating that the NAP elements can confer inducibility on a heterologous promoter. In addition, the induction was superinduced in the presence of cycloheximide (data not shown), showing that the activation through NAP elements is indeed an immediate-early response. These results indicate that the NAP elements mediate activation by NGF and KC1.
In contrast, the 3SP1 TKCAT construct failed to show any induction by either NGF or KCl (Fig. 4B) . Since the SP1 site is required in the context of the nur77 minigene (Fig. 3 ) but itself cannot function as an inducible element, we interpret these data to indicate that the SP1 element acts as an essential element for nur77 promoter function rather than an inducible element. In the context of the thymidine kinase basal promoter, which contains SP1 sites, the NAP elements can function to confer inducibility.
JunD is a component of NAP element binding activity in PC12 cell nuclear extracts. To identify which proteins are bound to the NAP elements, an EMSA was employed to detect NAP element binding activity in PC12 cell nuclear lysates with 32P-labeled NAP2 synthetic oligonucleotides used as probes. In nuclear extracts of cells stimulated with NGF for 20 min, we detected specific NAP binding activity (Fig. 5) . This (Fig. 8A) . The nur77 promoter activity could be detected as luciferase activity. In cotransfection experiments with vectors that express proteins of the Fos/Jun family, only expression of JunD was able to transactivate the nur77 promoter (about 40-fold; Fig. 8B ). In contrast, expression of either c-Fos, c-Jun, or JunB was unable to transactivate nur77 (Fig. 8B) . Thus, JunD protein is unique among members of the Fos/Jun family in its ability to transactivate nur77.
To determine whether JunD transactivates nur77 through the NAP elements, we mutated the NAP elements in the context of the luciferase reporter construct (Fig. 8A) . When either NAPI (86LucM5) or NAP2 (86LucM7) was mutated, transactivation by JunD decreased to 30 and 10% of that of the wild-type promoter, respectively (Fig. 8C) . When both NAP1 and NAP2 elements were mutated (86LucM57), induction by JunD was abolished. These results indicate that transactivation of nur77 by JunD is mediated through the NAP elements, which we have shown to be the crucial elements for activation by NGF and KCl. When PC12 cells were transfected with a JunD expression vector and then stimulated with either NGF or KCl, a further increase in transactivation of nur77 was observed (Fig. 8D) (Fig. 9A) . The JunD mutant, which has its DNA binding domain deleted, should retain the capacity to form homodimers or heterodimers through the leucine zipper region but should be unable to bind DNA. Thus, we reasoned that it would be possible to block the function of wild-type, endogenous JunD by overexpressing such a JunD dominant-negative mutant in cells.
We first characterized the properties of the JunD mutant protein. Wild-type and mutant JunD proteins were generated by in vitro transcription-translation and labeled with [35S]methionine (Fig. 9B) . To test their abilities to form dimers, labeled wild-type or mutant JunD was mixed with similarly labeled c-Fos to allow dimerization. The resulting proteins were subjected to immunoprecipitation with either anti-c-Fos or anti-JunD antibodies, and the precipitated proteins were fractionated by SDS-10% PAGE (Fig. 9B) . Both wild-type and mutant JunD were coprecipitated by the anti-c-Fos antibodies, even though the anti-c-Fos antibodies did not recognize either form of JunD (Fig. 9B) . Likewise, immunoprecipitates with anti-JunD antibodies contained c-Fos protein. These data indicate that the mutant JunD can form heterodimers with c-Fos as efficiently as the wild-type JunD.
To assess the ability of either the mutant or the wild-type JunD to bind DNA, the JunD proteins were subjected to an EMSA with 32P-labeled AP1 oligonucleotide used as a probe in either the presence or the absence of c-Fos (Fig. 9C) . While c-Fos or JunD by itself could not form a DNA-protein complex, the mixture of c-Fos and wild-type JunD formed a strong complex with the AP1 oligonucleotide. In contrast, no DNA binding activity could be detected with the mutant JunD, even in the presence of c-Fos (Fig. 9C) . Moreover, when the mutant JunD protein was included in a binding reaction mixture with the wild-type JunD, the DNA binding activity of the wild-type protein was abolished (Fig. 9D) . Taken form heterodimers but cannot bind DNA and interferes with the DNA binding activities of the wild-type JunD in a dominant-negative fashion.
We next questioned whether this dominant-negative mutant JunD can block the induction of nur77 by NGF and KCl. An expression construct with the mutant JunD coding sequence driven by the cytomegalovirus promoter was transiently cotransfected with the 126/77TR nur77 minigene into PC12 cells. As expected, transfected cells that were unstimulated did not show induction of nur77, whereas cells transfected with the parental vector showed strong induction of the endogenous and transfected nur77 upon stimulation by NGF or KCl (Fig.  10) . However, when the mutant JunD expression vector was titrated into the transfection mixture, activation of the transfected nur77 by either NGF or KCl was inhibited in a dosedependent manner (Fig. 10 ). Since these transfections were carried out by electroporation under conditions in which most of the cells die, a large proportion of the surviving cells were transfected. Under these conditions, the induction of the endogenous gene was also affected by the overexpressed mutant JunD. The expression of a dominant-negative JunD protein is thus able to effectively block the induction of nur77 by NGF or KCl. Similar results were obtained when the nur77 promoter-luciferase construct was used as a reporter in place of the 126/77TR minigene (data not shown). From these results taken together, we conclude that JunD protein is indeed a transcription activator involved in the induction of nur77 by NGF or KCl in PC12 cells. DISCUSSION NGF and KCI activate nur77 through distinct but convergent signalling pathways. PC12 cells respond to NGF treatment and membrane depolarization with vastly different biological consequences (21, 22) . Paradoxically, many of the same immediate-early genes are induced in both processes, suggest- ing that the immediate-early proteins synthesized under these conditions might have disparate activities through different combinatorial effects or posttranslational modifications (3) . In this regard, it is interesting that Nur77 synthesized upon NGF or KCl treatment is differentially phosphorylated (25) . 126/77TR minigene, 6 pug of pPGKB-gal, and either 20 pg of the parental pCMV plasmid or 10 or 20 pug of pCMVJunDmut expression plasmid (adjusted to a total of 20 pg with the parental expression plasmid pCMV5) by electroporation. After transfection, cells were either unstimulated (-) or stimulated with NGF or KCl for 1 h as indicated. Expression of the transfected and the endogenous nur77 genes was analyzed by S1 nuclease protection assay. The RNA amount for S1 protection assay was normalized to the ,-galactosidase activity of the extract, which serves as a control for transfection efficiencies.
That many of the same genes are induced by NGF and KCI treatment in PC12 cells suggests that these agents either work through different signalling pathways that act upon distinct regulatory sequences on the same genes or work through signalling pathways that converge upon the same transcription factors, which activate the identical genes. In the case of c-fos, the sequence elements necessary for NGF and KCl induction are separable: NGF induction requires the serum response element centered at nt -310 (53, 63) as well as two CRE-like elements (17) , and membrane depolarization requires a CRElike sequence centered at nt -60 (53, 55) . These data argue that NGF and KCl work through different signalling pathways that act upon distinct regulatory sequences to activate c-fos. In contrast, extensive promoter analysis presented in this study shows that two similar APi-like sequences, NAP1 and NAP2, are necessary and sufficient to mediate induction by both NGF and KCl (Fig. 3 and 4) . Thus, the sequence requirements for induction of nur77 by NGF and KCl appear indistinguishable.
Nevertheless, NGF and KCl clearly work through distinct signalling pathways to induce nur77, as they are differentially affected by specific kinase inhibitors (Fig. 1) . Induction by NGF does not require phorbol ester-sensitive PKC-or CaMII kinase-dependent pathways (Fig. 1A and C) but is partially mediated through a PKA-dependent pathway (Fig. 1B) . NGF binds to a cell surface receptor complex composed of a pl4oPrototrk and a p75NGFR molecule (27, 30) , resulting in the activation of an intrinsic receptor tyrosine kinase (31) . Subsequent signalling events involve the activation of many kinases, including the MAP (mitogen-activated protein) kinases (24, 57, 62, 69 (Fig. IC) . In addition, whereas PKC-dependent pathways are not involved in KCl induction of nur77 (Fig. 1A) , PKA may be involved in nur77 activation (Fig. 1B) . The activation of c-fos and zif268/NGFI-A by KCl has been shown to be attenuated in PKA-deficient PC12 cell lines (18) . However, as neither membrane depolarization nor Ca2" affects cAMP levels in PC12 cells (56) (33, 34, 42, 46, 50) . In the unstimulated PC12 cell, c-jun,junB, and c-fos are not expressed (3 Since the dominant-negative JunD retains the ability to form dimers, the absence of other Fos/Jun proteins allows us to conclude that the dominant-negative mutant blocks JunD action and not that of other members of the Fos/Jun family.
Since CREB is known to be involved in the activation of c-fos by both NGF and membrane depolarization in PC12 cells (17, 56) , and since a CRE oligonucleotide competes with the NAP element for binding to nuclear proteins (Fig. 5) (Fig. 6B) , and since a CRE oligonucleotide competes with the NAP element for nuclear protein binding (Fig. 5) , it is possible that another member of the CREB family of proteins might participate in nur77 activation. The ability of JunD to heterodimerize with CREB or CREM bZIP family members is consistent with this possibility (23, 39) .
Distinct regulation of nur77 transcription. We now have sufficient information concerning the transcriptional activation of nur77 to recognize that distinct sequences regulate its induction in different cell types. In fibroblasts, the rapid and transient activation of nur77 induced by serum growth factors is actually the superimposition of two distinct transcriptional responses: an immediate-early response which is independent of new protein synthesis and a delayed-early response which is dependent on new protein synthesis (66) . The cis-acting sequence elements required for immediate-early activation of the gene were localized to a region of the promoter spanning nt -126 to -87 (66) . This region contains a CArG-like element and the adjacent Ets binding site; both are required for significant induction (66) . In contrast, delayed-early expression of nur77 in fibroblasts is mediated through nt -86 to -26 in the promoter, which correspond to the NAP elements and SP1 and Zif268 sites identified in this study as being responsible for the immediate-early activation in PC12 cells (66) . Thus, sequence elements that mediate the immediate-early response in one cell type can mediate the delayed-early response in another. In contrast to the findings for fibroblasts and PC12 cells, the promoter region responsible for the nur77 activation by adrenocorticotrophic hormone in the adrenal cortical cell line Y-1 was localized further upstream (11) . In T lymphocytes, activation of nur77 by TPA requires sequences between nt -378 and -332, whereas activation by apoptotic signals delivered through the T-cell receptor requires sequences between nt -332 and -151 (37) . Taken together, these findings point to a multiplicity of regulatory mechanisms that control the transcription of nur77 in different cell types.
